Huapont Life Sciences Co.,Ltd. (SHE: 002004)

Market Cap	7.60B
Revenue (ttm)	11.65B
Net Income (ttm)	249.17M
Shares Out	1.97B
EPS (ttm)	0.13
PE Ratio	30.54
Forward PE	n/a
Dividend	0.22 (5.71%)
Ex-Dividend Date	Jun 3, 2024

Volume	33,710,900
Average Volume	26,766,970
Open	3.800
Previous Close	3.840
Day's Range	3.800 - 3.920
52-Week Range	3.680 - 5.230
Beta	0.46
RSI	26.53
Earnings Date	Apr 19, 2025

About Huapont Life Sciences

Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and raw materials. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and ophthalmology, as well as health management products. In addition, the company provides pesticide technical, intermediate and preparation products, and GLP registration technical services. Furthe...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1992
• Employees: 12,580
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002004

Financial Performance

In 2023, Huapont Life Sciences Co.,Ltd.'s revenue was 11.59 billion, a decrease of -12.38% compared to the previous year's 13.23 billion. Earnings were 302.12 million, a decrease of -30.30%.